Cargando…
Landscape of exitrons in gastric cancer
BACKGROUND: Exitron is a new type of non-canonical alternative splicing. Accumulating evidence implies exitron may have pathological function and contribute to another source of anti-tumor immunogenicity in various cancers. Its role in gastric cancer remains poorly understood. Large-scale, multi-omi...
Autores principales: | Zhang, Yihao, Ye, Gengtai, Yang, Qingbin, Zheng, Boyang, Zhang, Guofan, Hu, Yanfeng, Yu, Jiang, Li, Guoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494173/ https://www.ncbi.nlm.nih.gov/pubmed/36137412 http://dx.doi.org/10.1016/j.ebiom.2022.104272 |
Ejemplares similares
-
Enter exitrons
por: Staiger, Dorothee, et al.
Publicado: (2015) -
Integrated protocol for exitron and exitron-derived neoantigen identification using human RNA-seq data with ScanExitron and ScanNeo
por: Wang, Ting-You, et al.
Publicado: (2021) -
Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022) -
N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop
por: Yang, Qingbin, et al.
Publicado: (2023) -
N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop (Adv. Sci. 23/2023)
por: Yang, Qingbin, et al.
Publicado: (2023)